April 28, 2017Open Access

Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

In adults ≥ 60 years of age with T1D and T2D using MDI, CGM use was high and associated with improved HbA1c and reduced glycemic variability. Therefore, CGM should be considered for older adults with diabetes using MDI.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Ruedy et al. (Fri,) studied this question.

synapsesocial.com/papers/69d977398fbc15f99e68417b https://doi.org/https://doi.org/10.1177/1932296817704445

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Diabetes Numeracy and Blood Glucose Control: Association With Type of Diabetes and Source of Care2014 · 46 citations
2The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus2011 · 203 citations
3Response to Comment on American Diabetes Association. <i>Standards of Medical Care in Diabetes—2017</i>. Diabetes Care 2017;40(Suppl. 1):S1–S1352017 · 122 citations
4Reduced Awareness of Hypoglycemia in Adults With IDDM: A prospective study of hypoglycemic frequency and associated symptoms1995 · 648 citations
5Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment2009 · 313 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo